composition of surfactant (1 8), vitamin E may provide protection
Despite an appreciation of the toxic effects of oxygen on the lung, hyperoxia therapy remains a necessary mainstay for therapeutic support of infants born with inadequate lung function. Hyperoxia treatment has been associated with the development of bronchopulmonary dysplasia in the chronically exposed newborn infant (23). Furthermore, we have recently demonstrated that hyperoxia compromises the maturing pulmonary surfactant system of the neonatal rabbit, implicating a role of acute hyperoxia toxicity in the course of neonatal respiratory distress syndrome (36).
The use of vitamin E to prevent hyperoxia-associated lung injury has been investigated clinically, with conflicting reports on its benefit in newborns with respiratory distress syndrome (1, 12, 13, 2 1, 29) . Studies utilizing animal models have added to this controversy. Some investigators have reported a protective effect by vitamin E against certain morphologic and antioxidant enzyme alterations and loss in pulmonary gas exchange resulting from hyperoxia exposure (8, 37) . Other studies, however, have observed no effect of vitamin E on hyperoxia-associated changes in morphology and endothelial integrity (8, 16 ). Because of the proported antioxidant activity of vitamin E and the known lipid to the pulmonary surfactant system. In spite-of the large interest in vitamin E, its influence in specifically reducing the vulnerability of the surfactant system to oxidant injury has not been previously studied.
In view of the rapid changes which occur in the pulmonary surfactant system with birth and the onset of breathing and the known susceptibility of the newborn lung to hyperoxia toxicity, the effects of vitamin E on the pulmonary surfactant system in rabbits exposed to air or hyperoxia were evaluated from birth through 48 h of life.
MATERIALS AND METHODS
Gestationally timed pregnant rabbits were obtained from a local supplier (Morrison Rabbitry, West Branch, IA). Day of mating was considered day zero. At 31 d gestation (full-term) pups were delivered by Caesarian section under 2.5% halothane:oxygen anesthesia in order to minimize fetal asphyxia. Newlv delivered animals were randomlv divided into four mouvs for a& or hyperoxic exposure with treatment at 1 and 22 h of life, with either vitamin E (dl-a-tocopherol, free alcohol) 100 mg/kg subcutaneously, or vehicle placebo. The pups were housed immediately after birth in 4L chambers maintained at 36"C, 80% humidity. Continuous use of a 3-p filter in-line with the gas supply, and ultraviolet exposure of chambers before use were utilized for bacterial control. Gas flow, either air or 100% oxygen, was 4 L/min. Oxygen concentration was monitored in air and oxygen exposure chambers with an OM-14 oxygen analyzer (Beckman Instruments, Inc, Schiller Park, IL) maintaining a 21 % concentration of oxygen for the air chamber, and greater than 95% for the hyperoxia chamber. All pups were given a 5% dextrose/saline solution by subcutaneous injection (1 m1/30 g body weight) at 6 h of life. Gavage feedings were carried out every 24 h using a specially formulated Purina newborn rabbit nutrient solution (35) . The nutrient solution contained 1.7 pg/ ml vitamin E (dl-a-tocopherol) which provided a total nutritional contribution of 0.28 mg/kg of vitamin E over the 48-h experimental time period. At 48 h the animals were given a lethal dose of sodium pentobarbital and placed in 100% oxygen to metabolically degas the lungs.
Lungs from individual pups were used either for pressure:volume determination of lung compliance followed by lavage fluid collection and subsequent surfactant analysis, or were processed for light level microscopic evaluation. For pressure:volume determination of static compliance, the trachea was cannulated immediately upon sacrifice of the pup. The lungs were inflated at approximately 10 cm H20/min using a U-tube water manometer. At given pressure intervals, volumes were recorded for construction of the pressure:volume curve. Maxi-mum volume at 30 cm H 2 0 pressure was maintained for 5 min before deflation was performed. A drop in pressure of more than 10 cm H 2 0 during this time was considered to be the result of an air leak, and the animal was excluded from analysis. Subsequent to this 5-min period the lungs were reinflated to 30 cm H 2 0 pressure. This volume was recorded as V30. Deflation was performed at the same rate, with volumes again recorded at given pressure intervals. Volumes were corrected for air compression in the system and expressed as percentage of volume at 30 cm H 2 0 pressure. Calculations of pressure at three different volumes provided a quantitative index for comparing compliance in air and hyperoxia-exposed animals: 30% V30 on inspiration and 80% V30, 30% V30 on expiration. The V30 measurement was selected as an indicator of maximal distensibility of lung for comparison between the two treatment groups.
Subsequent to pressure:volume determinations, the animals were placed head-down on an inclined plane to facilitate passive gravitational fluid collection and lavaged five times via a tracheal cannula with normal saline. The volume used was 80% of V30. To qualify for inclusion in lavage analysis, total fluid collected from lungs of each animal had to equal at least 85% of the volume introduced. This technique has been shown to provide for recovery of 90% of extracellular surfactant phospholipid (27) . Lavage fluid for each individual animal was pooled and centrifuged at 150 g for 10 min. The resulting supernatant was frozen at -20°C until analyzed.
All lavage samples were analyzed in duplicate. Chloroform was redistilled just before use, and methanol was HPLC grade. One-milliliter aliquots of lavage samples were extracted with chloroform:methanol(2: 1 v/v) after the procedure of Bligh and Dyer (4). The chloroform layer was recovered and dried under N2 at 45°C. Separation of individual phospholipids was accomplished using thin layer chromatography on Whatman LK5D plates (Whatman Inc, Clifton, NJ) with the solvent system chloroform:methanol:acetic acid:water (50:35:4:2), as developed by Rooney et al. (27) . This system provided for the separation of PC, PS + PI, PE, and PG. These individual phospholipids were identified using standards obtained from Sigma Chemical Company, St Louis, MO. Phospholipids were visualized with an iodine vapor system. Individual phospholipids were quantitated by determining the phosphorous content using the method of Bartlett (3) . Addition of standard phospholipids to lavage samples indicated 9 1 % recovery of phospholipid with these procedures.
After completing the lavage procedure, the wet lung weight was determined and lung weight was obtained on the left lung after drying in an oven at 55°C for at least 6 d. The right lung portion was used for protein and DNA analysis. The right lung tissue was homogenized in a lox volume ice cold potassium phosphate buffer (pH 7.4) for 30 s using a Polytron (Brinkmann Inst, Westbury, NY) on high speed. DNA content was determined using a method described by Richards (25). Protein was analyzed by a modified Lowry method (2, 30) . In randomly selected pups from each treatment group, lung tissue homogenates were analyzed for vitamin E content by HPLC, using modified methods of Westberg et al. (38) . Contamination of lung tissue by Vitamin E contained in blood was found to be negligable and, therefore, the lung was not perfused before homogenation for vitamin E determination. Approximately 200 mg of lung tissue from individual rabbits was extracted, dried under Nz, and redissolved in 0.14 ml n-hexane for injection of 0.1 ml onto a u-Bondapak-NH2 column #84040 (Waters Associates, Inc, Milford, MA). Ethanol (0.8%) in n-hexane was used as the mobile phase with a flow of 2.0 ml/min. Spectrophotometric detection was achieved by use of a Spectroflow Monitor SF 770 and a GM 770 Monochrometer (Schoeffel Instruments Division, Kratos, Inc, Westwood, NY) at 280 nm. A standard curve of 0.2-2.0 pg a-tocopherol was employed and found to give a linear response by peak height analysis. Extraction of standard dl-atocopherol added to homogenate showed this procedure to provide essentially complete recovery of a-tocopherol from tissue homogenates.
The lungs of animals used for morphologic evaluation were inflated by tracheal infusion of a solution of cacodylate-buffered glutaraldehyde (4% solution, pH 7.3) at a pressure of 20 cm HzO with the chest cavity open. Fixation by inflation at a controlled pressure was performed to eliminate possible artifactual differences due to postmortem absorption atelectasis of animals breathing 100% oxygen. Tracheas were then ligated, and the lungs were excised and immersed in fixative for 24 h at 4°C. The left lung was used for sectioning in the following manner: a full cross-section was cut from lower portion of the lower lobe, and five blocks approximately 4 mm2 were randomly taken from the upper portion of the lower lobe and from the upper lobe. The tissues were postfixed in phosphate-buffered osmium tetroxide (2%) for 1-2 h, washed in distilled water, en bloc stained with uranyl acetate, dehydrated in graded methanols and embedded in Epon 812. Thin sections (1-2 p) were stained with toluidine blue for light microscopy.
Light level morphometric studies were performed at a magnification of x400 with an A 0 microscope equipped with a 25-square eyepiece grid. While avoiding large vessels and airways, five random fields per section were selected, and line intersections were scored as to their presence over interstitial tissue, air space, or capillary space. At x 100 magnification a quantitation of air spaces containing erythrocytes relative to clear airspaces was performed using the same grid to count representative airspaces under or next to line intersections. Relative numbers of Type I, Type 11, and undifferentiated epithelial cells were determined at xlOO magnification using identification criteria outlined by Khosla et al. (17) . Cells lying under grid intersections were counted using fields from each of five sections to achieve a total of 150-200 cells/animal. Slides were coded so that counting was achieved without knowledge of treatment received by animals. Statistical analysis of all parameters was performed using the Student's t test for grouped comparisons.
Vitamin E and placebo vehicle were contributed by HoffmanLaRoche Inc, Nutley, NJ.
RESULTS
Body weights, dry 1ung:body weight ratios, and lung DNA:protein ratios are reported in Table 1 . All three parameters, reflecting whole body and lung growth, were unaffected by 48 h of hyperoxia exposure or vitamin E treatment in comparison with air-exposed, placebo-treated controls. In addition, survival and gross indications of well-being were not different in any treatment group. Lung a-tocopherol content (Table 2) reflected doses administered, with an approximate 50-fold increase in the groups treated with vitamin E. There was no effect of hyperoxia exposure on lung vitamin E content, which agrees with the findings by Bucher and Roberts (7) in the newborn rat.
Determinations of maximum distensibility (V30) from pressure:volume analysis are shown in Figure 1 . A decrease in VjO was observed in animals exposed to hyperoxia + placebo, as compared with air-exposed, placebo-treated controls. Vitamin E treatment prevented this decrease in maximum distensibility in animals exposed to hyperoxia, resulting in V30 values of pups in hyperoxia + vitamin E which were similar to those of air-exposed pups. In air-exposed animals, vitamin E treatment did not appear to have any effect on V30. Figure 2 illustrates means of actual pressure:volume curves expressed as percentage of maximum distensibility (V,,). In pups treated with placebo and exposed to hyperoxia, there was an apparent right shift of the inflation curve and a slight left shift of the deflation curve. Figure 3 shows a quantitative comparison of three inflationldeflation points calculated from individual pressure:volume curves. Hyperoxia exposure lead to an increase in the pressure necessary to inflate the lungs to 30% of V3, (P30i). Decreases in pressures on deflation at 80% of V30 and 30% of V30 (PsOd, P30d), (Figs. 3B and C) were also observed in pups in the hyperoxia + placebo treatment group. With vitamin E treatment these pressure:volume changes associated with hyperoxia were abolished. Lung lavage surfactant phospholipid content is illustrated in Figure 4 . Exposure to hyperoxia with placebo treatment resulted in a lower content of lavage phospholipid with levels 74% of airexposed controls. In animals treated with vitamin E and exposed to hyperoxia, lavage phospholipid content was found to be identical to control values.
The various phospholipid components recovered by lavage were determined and are reported in Table 3 . Exposure to hyperoxia did not significantly alter the relative composition of the phospholipids, although the concentration of phosphatidylglycerol was consistently lower in animals exposed to hyperoxia with placebo treatment. Comparison of animals administered vitamin E with those given placebo vehicle also revealed no changes in overall phospholipid composition recovered in lavage.
Results from morphologic analysis of the four treatment groups are presented in Table 4 . Determination of the relative concentrations of Type I, Type 11, and undifferentiated epithelial cells revealed a statistically significant decrease in the percentage of Type I cells with a corresponding slight increase in percentage of Type I1 cells in hyperoxia-exposed pups given placebo. This hyperoxia effect was eliminated with vitamin E tretment. In placebo-treated pups, hyperoxia exposure tended to increase capil1ary:interstitium ratios over air-exposed controls, but did not alter air:tissue ratios. Vitamin E treatment was found to have no effect on either capil1ary:interstitium or air:tissue ratios. Evaluation of percentage of air spaces containing erythrocytes revealed a hyperoxia-associated increase compared with air-exposed controls, Vitamin E treatment abolished this hyperoxiainduced increase in percentage air spaces containing erythrocytes. DISCUSSION Although controversy exists with regard to the beneficial effects of vitamin E (a-tocopherol) in newborns, studies in hyperoxiaexposed newborn animals have shown vitamin E to offer protection to the lung against selected aspects of functional, biochemical, and morphologic changes associated with hyperoxia (8, 34, 37) . This report is the first to examine the effect of vitamin E on the pulmonary surfactant system. In this study, vitamin E was found to be effective in preventing hyperoxia-induced decrease in total airway phospholipid recovered by lung lavage.
In pressure:volume studies, animals treated with hyperoxia + placebo exhibited a right shift in the inflation phase of the pressure:volume curve (Fig. 2) . This is consistent with a decrease in compliance and may reflect a compromise in surfactant function. A left shift in the deflation phase of the curve was also observed in this same treatment group. This effect may be due to air entrapment or a stiffening of lung tissue which could diminish the tendency for collapse with lowering of pressure. A similar finding in rats exposed to hyperoxia was reported with the suggestion that alveoli are "held open" as a result ofhyperoxia induction of a rapid increase in lung collagen content (26) . Vitamin E treatment completely abolished hyperoxia-induced decreases in pulmonary compliance and distensibility (Figs. 1,2,  3 ). This finding is consistent, but may not be limited to a protection of surfactant components in the lung. This apparent protection with vitamin E is consistent with a study by Wender et al. (37) , who demonstrated fewer areas of atelectasis and emphysema in lung tissue of hyperoxia-exposed newborn rabbits after vitamin E treatment. Bucher and Roberts (8) also reported vitamin E reversal of hyperoxia effects on pulmonary static compliance in the neonatal rat. In this study, deflation pressure:volume curves were shifted to the right after 6 d of hyperoxia, in contrast to our observations of prevention of a left shift in rabbit pups after 48 h of hyperoxia. Additionally, vitamin E treatment did not inhibit maximum distensibility changes in the hyperoxia-exposed neonatal rat as reported here. These differences probably reflect the changing status of the lung according to the duration of hyperoxia exposure and the age of the animal at the time of study. Species differences may also be involved.
The amount of phospholipid recovered from the lung airspaces by saline lavage was found to be lower with hyperoxia exposure, consistent with previous time-dependent studies in the newborn rabbit (36), and reports in other species (5, 15,22,24) . Hyperoxia tective action is based on its association with biological memtoxicity is thought to occur through the generation of free radicals branes and involves antioxidant protection and physical stabiliwhich are capable of inducing lipid peroxidation as well as zation of the unsaturated fatty acid components of membrane injuring protein and DNA (1 1). Our observations on the effect phospholipids (20). Surfactant phospholipid is known to contain of hyperoxia on lavage phospholipid content could involve a free unsaturated fatty acids which are felt to have a critical role in radical mediated degradation of preformed phospholipid in the the functional integrity of surfactant (1 8). Because vitamin E has surfactant lining. One proposed mechanism for vitamin E pro-been found and quantitated from lung lavage fluid extracts (14, Table 3 . Effects of hyperoxia and vitamin E treatment on the composition ofphospholipids recovered by lung lavage in newborn rabbits* Phospholipidt Air + placebo Air + vitamin E Hyperoxia + Placebo Hyperoxia + vitamin E (% of total) (n = 7) ( n = 13) ( n = 9) (n = 10) * See Table 1 footnote. No significant differences were observed among treatment groups. t Abbreviations: PC, phosphatidylcholine; PS, phosphatidylserine; PI, phosphatidylinositol; PE, phosphatidylethanolamine; and PC, phosphatidylglycerol. 3 I), it is logical to assume that vitamin E could have a protective function in the extracellular surfactant lining. The quantity of vitamin E necessary to protect unsaturated fatty acids in surfactant would not be expected to be large because molar ratios of polyunsaturated fatty acids to vitamin E or 1000: 1 are reported to provide adequate antioxidant protection in membranes (33); however, the absence of significant changes in phospholipid composition (Table 3) would argue against a degradation mechanism. Alternatively, it is possible that oxygen radicals may be acting on critical processes in or on the Type I1 cells, resulting in impairment of surfactant phospholipid synthesis, release, and/or reuptake. According to Tappel (32), vitamin E can function nonspecifically as an antioxidant and could be expected to exert a protective action by terminating free radical reactions intracellularly including within membranes, as well as extracellularly to protect any cellular component or product. As noted previously, it has been suggested that vitamin E can specifically associate with the cell membrane to maintain stability (20). In view of the potential multiple targets of hyperoxia toxicity in the lung and the apparent vitamin E protection to more than one target of hyperoxia, further studies examining the effects of hyperoxia on surfactant synthesis and release, and examination of the localization and disposition of vitamin E within the lung would be of value.
In addition to phospholipid analysis, we evaluated the lung morphometrically to determine whether vitamin E exerted any action on the concentration of the Type I1 cells in the alveolar walls of hyperoxia-exposed animals, as well as to determine whether the lung tissue in general was protected from hyperoxia injury. The morphologic evidence of pulmonary oxygen toxicity observed in our newborn rabbit studies followed the pattern of response reported in the newborn rat and in many adult species (6, 9) . Effects of hyperoxia exposure for 48-72 h as described by Kistler et al. (19) in the adult rat included pulmonary edema, increased interstitial thickness, and swelling of the capillary endothelium and alveolar epithelium. Changes in the epithelial cell composition reported by Crapo et al. (10) reflect proliferation of Type I1 cells in compensation for injured or lost Type I cells.
Results of this study are in agreement with this pattern of hyperoxia toxicity. Vitamin E appeared to act selectively in protecting against changes in cell-type composition in the lung parenchyma, and inhibiting hyperoxia-associated increase in erythrocytes present in air spaces, but offered no protection against increased capil1ary:interstitial ratios. Hansen et al. (16) measured vascular permeability and lung water in hyperoxiaexposed newborn lambs and also reported no protective effect of vitamin E on these parameters.
Previous evaluations of vitamin E protection against hyperoxia toxicity in the lung have yielded conflicting results (7, 12, 13, 16, 2 1, 29, 37). There are several possible explanations for this apparent inconsistency. The parameters utilized to assess the status of the lung (physiologic, biochemical, morphometric) have varied and are not equally affected by hyperoxia (6, 9) . Vitamin E may protect against only selected components of hyperoxiainduced lung injury, such as the surfactant system; thus, it may be critical to examine the lung with a comprehensive approach in order to clearly understand the protective role of vitamin E. Another possible source of difference is the timing of both hyperoxia exposure and vitamin E treatment. Because the amount of surfactant recovered by lavage increases as much as 10-fold with air breathing in the first hours of life (28), hyperoxia exposure could compromise the release of surfactant into the airway. For maximal effectiveness, vitamin E treatment would have to be initiated at the onset of oxygen exposure and breathing. It is also known that the lung's response to hyperoxia progresses from an exudative phase to a proliferative phase with continued exposure (1 1). It is possible that vitamin E exerts a protective action only in the first stage of oxygen toxicity. Clinical studies which have failed to observe the protective effect of vitamin E may have included infants affected by oxygen exposure before having achieved adequate lung tissue levels of vitamin E. Finally, baseline vitamin E status, nutritional supplementation with vitamin E, and route of administration, dose and dosage form of vitamin E are all factors which may influence the response of subjects to pharmacologic doses of vitamin E. It appears likely that vitamin E treatment which corrects a vitamin E deficiency state benefits the lung, but once adequate threshold levels of vitamin E are achieved nutritionally, no further protec-18. King, R. J., and Clements, J. A.: Surface active materials from dog lung. 11. tion can be provided even with pharmacologic doses (8) of vitamin E less than that found in colostrum (7, 8 
